Skip to main content

Astratus

Astratus provides a rapid, high-throughput laboratory platform that significantly reduces antimicrobial susceptibility testing (AST) time for urine samples. The automated system replaces manual, labor-intensive methods, enabling faster, more accurate results and more targeted antibiotic prescribing. This helps laboratories improve antimicrobial stewardship and alleviate workforce pressures.

Reading, United Kingdom · HQ
Founded 20248300+ followers
Updated 10 days ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Antibiotic resistance is driven by the misuse and overuse of antibiotics, often because patients are prescribed treatments before their antimicrobial susceptibility testing (AST) results are known. Traditional urine AST methods are manual, labor-intensive, and take 2 to 7 days to produce results, delaying optimal treatment and increasing the risk of antimicrobial resistance.

Solution

Astratus offers a rapid, accurate, high-throughput laboratory platform that significantly reduces time-to-result for antimicrobial susceptibility testing. The platform automates the manual, multi-step process of urine AST, replacing labor-intensive methods with a single, high-throughput system. This enables laboratories to deliver faster, more accurate susceptibility results, allowing clinicians to prescribe more targeted antibiotics. By streamlining workflows and reducing hands-on time, Astratus helps laboratories increase productivity, relieve workforce pressures, and strengthen antimicrobial stewardship programs.

Target Audience

Primary customers are clinical microbiology laboratories and hospital diagnostic departments that perform high volumes of urine antimicrobial susceptibility testing and need faster, more efficient workflows.

Features

  • High-throughput automated platform that processes hundreds of urine AST samples with minimal manual intervention
  • Rapid time-to-result significantly shorter than the traditional 2-7 day turnaround
  • Integrated workflow that replaces multiple manual steps with a single, streamlined system
  • Designed for accuracy and consistency, reducing reliance on subjective manual analysis
  • Supports antimicrobial stewardship by enabling faster, targeted prescribing decisions
This profile is AI-generated and may contain inaccuracies.